Structural analysis of an anthrol reductase inspires enantioselective synthesis of enantiopure hydroxycycloketones and β-halohydrins

Xiaodong Hou, Huibin Xu, Zhenbo Yuan, Zhiwei Deng, Kai Fu, Yue Gao, Chang‐Mei Liu, Yan Zhang, Yijian RaoNature Communications 2023 · DOI

TL;DR

Researchers have identified and engineered a fungal enzyme, CbAR, capable of performing highly precise chemical "surgeries" on bulky molecules. By solving the enzyme's crystal structure, they created a variant (H162F) that produces enantiopure chiral alcohols—critical building blocks for pharmaceuticals—with nearly 100% purity and selectivity, overcoming a long-standing challenge in synthetic chemistry.

What Problem Does This Paper Address?

In the world of drug synthesis, "handedness" (chirality) is everything. Many medicines require a specific 3D orientation of atoms to work safely. Creating these "enantiopure" molecules—specifically hydroxycycloketones and $\beta$-halohydrins—is notoriously difficult.

The authors focus on a process called reductive desymmetrization. Imagine a symmetrical molecule that you want to turn into a specific asymmetrical one. For 2,2-disubstituted 1,3-cyclodiketones, there are ten possible isomeric products that could theoretically form. Traditional metal catalysts often struggle with the "bulkiness" of these molecules or fail to achieve high selectivity. While enzymes are a greener, more precise alternative, most natural enzymes aren't "roomy" enough to handle these large, complex substrates.

Methods

The team combined genomic mining, structural biology, and protein engineering:

  • Enzyme Discovery: They identified CbAR, an anthrol reductase from the fungus Cercospora sp., which naturally handles bulky substrates like emodin.
  • X-ray Crystallography: They solved the crystal structures of CbAR in various states: alone, bound to its natural substrate (emodin), and bound to non-natural substrates. This allowed them to see exactly how the enzyme "grabs" molecules.
  • Structure-Guided Engineering: By analyzing the binding pocket, they identified a "gate" loop (residues 209–216) and a key residue, His162. They used site-directed mutagenesis to create the CbAR-H162F variant, specifically designed to accommodate non-natural bulky ketones.
  • Biocatalysis: The engineered enzyme was used as a catalyst in aqueous buffers with a glucose-based system to recycle the necessary chemical energy (NADPH).

Datasets

This study did not use large-scale machine learning datasets. Instead, it relied on:

  • Structural Data: Four new protein structures were deposited in the Protein Data Bank (PDB): 7YB1, 7YB2, 8HFJ, and 8HFK.
  • Sequence Homology: They compared CbAR against known Short-chain Dehydrogenases/Reductases (SDRs) to build a phylogenetic tree and identify functional similarities.

Key Insights and Ideas

  • The "Gate" Loop: The researchers discovered that a specific flexible loop (residues 209–216) acts as a gatekeeper. In the "active" state, it closes over the substrate, stabilizing it for the reaction.
  • Tyr210 is the Anchor: This residue is the "MVP" of the binding pocket. It uses $\pi$-$\pi$ stacking (a type of molecular "velcro") to hold bulky aromatic rings in the perfect orientation for the reaction to occur.
  • Unlocking Promiscuity: By mutating Histidine 162 to Phenylalanine (H162F), the researchers broke a natural hydrogen bond that restricted the pocket. This "opened the door" for the enzyme to accept a much wider variety of industrial chemicals.
  • Sulfur-Halogen Bonding: In a fascinating mechanistic find, they observed that a Methionine residue (Met202) forms a rare sulfur-halogen bond with bromine-containing substrates, precisely orienting them for high-purity synthesis.

Key Results

  • Near-Perfect Selectivity: The engineered CbAR-H162F variant produced (2S, 3S)-ketols and (R)-$\beta$-halohydrins with >99% enantiomeric excess (ee). This means the enzyme almost never makes the "wrong-handed" version of the molecule.
  • High Efficiency: For many substrates, the conversion rate reached 99%, significantly outperforming previous enzymatic methods for these specific bulky targets.
  • Broad Scope: The enzyme successfully processed a variety of substrates, including those with methyl, chloro, and bromo groups, proving its versatility as a "Swiss Army knife" for synthetic chemists.

Limitations and Future Work

While CbAR-H162F is highly selective, its catalytic efficiency ($k_{cat}$) on non-natural substrates is still lower than its activity on its natural substrate, emodin. Some substrates, like simple acetophenone, showed no activity at all, suggesting there are still limits to its "promiscuity."

The authors suggest that future work could involve further "tuning" the gate loop and binding pocket to increase the reaction speed. Additionally, this study provides a blueprint for using structural analysis to "repurpose" other natural reductases for industrial green chemistry.

Summary updated

Abstract

Abstract Asymmetric reduction of prochiral ketones, particularly, reductive desymmetrization of 2,2-disubstituted prochiral 1,3-cyclodiketones to produce enantiopure chiral alcohols is challenging. Herein, an anthrol reductase CbAR with the ability to accommodate diverse bulky substrates, like emodin, for asymmetric reduction is identified. We firstly solve crystal structures of CbAR and CbAR-Emodin complex. It reveals that Tyr210 is critical for emodin recognition and binding, as it forms a hydrogen-bond interaction with His162 and π-π stacking interactions with emodin. This ensures the correct orientation for the stereoselectivity. Then, through structure-guided engineering, variant CbAR-H162F can convert various 2,2-disubstituted 1,3-cyclodiketones and α -haloacetophenones to optically pure (2 S , 3 S )-ketols and ( R )-β-halohydrins, respectively. More importantly, their stereoselectivity mechanisms are also well explained by the respective crystal structures of CbAR-H162F-substrate complex. Therefore, this study demonstrates that an in-depth understanding of catalytic mechanism is valuable for exploiting the promiscuity of anthrol reductases to prepare diverse enantiopure chiral alcohols.
BibTeX
@inproceedings{hou2023structural,
  author = {Xiaodong Hou and Huibin Xu and Zhenbo Yuan and Zhiwei Deng and Kai Fu and Yue Gao and Chang‐Mei Liu and Yan Zhang and Yijian Rao},
  title = {{Structural analysis of an anthrol reductase inspires enantioselective synthesis of enantiopure hydroxycycloketones and β-halohydrins}},
  booktitle = {Nature Communications},
  year = {2023},
  doi = {10.1038/s41467-023-36064-4},
}
Figure